Dr Reddy’s gets EU approval for osteoporosis biosimilar AVT03

Hyderabad-based Dr Reddy’s Labs has received European Commission approval for AVT03, a biosimilar of Prolia and Xgeva developed by Alvotech, to treat osteoporosis and bone conditions. The company will commercialise the product in the US, Europe and global markets.

Related Articles